Cite
Iwata T, Maruyama Y, Kawada T, et al. Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis. Acta Med Okayama. 2021;75(6):705-711doi: 10.18926/AMO/62810.
Iwata, T., Maruyama, Y., Kawada, T., Sadahira, T., Katayama, S., Takamoto, A., Sako, T., Wada, K., Edamura, K., Kobayashi, Y., Araki, M., Watanabe, M., Watanabe, T., & Nasu, Y. (2021). Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis. Acta medica Okayama, 75(6), 705-711. https://doi.org/10.18926/AMO/62810
Iwata, Takehiro, et al. "Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis." Acta medica Okayama vol. 75,6 (2021): 705-711. doi: https://doi.org/10.18926/AMO/62810
Iwata T, Maruyama Y, Kawada T, Sadahira T, Katayama S, Takamoto A, Sako T, Wada K, Edamura K, Kobayashi Y, Araki M, Watanabe M, Watanabe T, Nasu Y. Testosterone Recovery after Neoadjuvant Gonadotropin-Releasing Hormone Antagonist versus Agonist on Permanent Iodine-125 Seed Brachytherapy in Prostate Cancer Patients: A Propensity Score Analysis. Acta Med Okayama. 2021 Dec;75(6):705-711. doi: 10.18926/AMO/62810. PMID: 34955538.
Copy
Download .nbib